Rachel R Deer1, Leyla Akhverdiyeva2, Yong-Fang Kuo3, Elena Volpi4. 1. Sealy Center on Aging, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA; Division of Rehabilitation Sciences, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. Electronic address: rrdeer@utmb.edu. 2. School of Medicine, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. Electronic address: leakhver@utmb.edu. 3. Sealy Center on Aging, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA; Dept. of Preventive Medicine and Population Health, Office of Biostatistics, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. Electronic address: yokuo@utmb.edu. 4. Sealy Center on Aging, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA; Dept. of Internal Medicine, Division of Geriatrics, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. Electronic address: evolpi@utmb.edu.
Abstract
BACKGROUND & AIMS: Sarcopenia is now a billable ICD-10 geriatric condition characterized by low appendicular skeletal muscle mass (ASMM) and low function. There is an increasing need for portable, provider-friendly, cost-effective methods for estimating ASMM. The overall goal of this project was to create and validate a regression model for obtaining ASMM from Bioelectrical Impedance Analysis (BIA) measurements using Dual-energy X-ray Absorptiometry (DXA) as the reference. METHODS: Geriatric patients (≥65 years of age) were enrolled during an acute hospitalization. Body composition measurements were obtained through DXA and BIA devices. The ASMM prediction model was derived using stepwise multiple regression modeling. The model was 10 fold validated and tested as a screening tool (sensitivity, specificity, positive and negative predictive values) using the Foundation for the NIH Sarcopenia Project (FNIH) definition. RESULTS: The following variables were selected by stepwise regression modeling: sex, body mass index, max grip strength, and fat mass derived by BIA. The model was internally validated with 10 fold cross validation. Using the FNIH definition, the model was found to have a sensitivity of 80%, a specificity of 91%, a positive predictive value of 73% and a negative predictive value of 93%. CONCLUSIONS: We have developed a screening tool that can be easily used in geriatric patients to screen for sarcopenia. Once validated with a larger sample, the developed prediction model can be used to estimate ASMM using provider-friendly measurements and can be easily implemented as a sensitive screening tool for identifying patients at risk for sarcopenia. Those identified at risk would undergo further functional testing for diagnosis and treatment of sarcopenia.
BACKGROUND & AIMS:Sarcopenia is now a billable ICD-10 geriatric condition characterized by low appendicular skeletal muscle mass (ASMM) and low function. There is an increasing need for portable, provider-friendly, cost-effective methods for estimating ASMM. The overall goal of this project was to create and validate a regression model for obtaining ASMM from Bioelectrical Impedance Analysis (BIA) measurements using Dual-energy X-ray Absorptiometry (DXA) as the reference. METHODS: Geriatric patients (≥65 years of age) were enrolled during an acute hospitalization. Body composition measurements were obtained through DXA and BIA devices. The ASMM prediction model was derived using stepwise multiple regression modeling. The model was 10 fold validated and tested as a screening tool (sensitivity, specificity, positive and negative predictive values) using the Foundation for the NIH Sarcopenia Project (FNIH) definition. RESULTS: The following variables were selected by stepwise regression modeling: sex, body mass index, maxgrip strength, and fat mass derived by BIA. The model was internally validated with 10 fold cross validation. Using the FNIH definition, the model was found to have a sensitivity of 80%, a specificity of 91%, a positive predictive value of 73% and a negative predictive value of 93%. CONCLUSIONS: We have developed a screening tool that can be easily used in geriatric patients to screen for sarcopenia. Once validated with a larger sample, the developed prediction model can be used to estimate ASMM using provider-friendly measurements and can be easily implemented as a sensitive screening tool for identifying patients at risk for sarcopenia. Those identified at risk would undergo further functional testing for diagnosis and treatment of sarcopenia.
Authors: Anna Paola Cerri; Giuseppe Bellelli; Andrea Mazzone; Francesca Pittella; Francesco Landi; Antonella Zambon; Giorgio Annoni Journal: Clin Nutr Date: 2014-09-21 Impact factor: 7.324
Authors: R Reiter; B Iglseder; W Treschnitzer; R Alzner; B Mayr-Pirker; M Kreutzer; C Pirich; H Kässmann; P Dovjak; J Reiss Journal: Arch Gerontol Geriatr Date: 2018-10-26 Impact factor: 3.250
Authors: Rachel R Deer; Jared M Dickinson; Jacques Baillargeon; Steven R Fisher; Mukaila Raji; Elena Volpi Journal: J Gerontol A Biol Sci Med Sci Date: 2019-09-15 Impact factor: 6.053
Authors: Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni Journal: J Am Med Dir Assoc Date: 2011-03-04 Impact factor: 4.669
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Jens Reiss; Bernhard Iglseder; Martina Kreutzer; Ingrid Weilbuchner; Wolfgang Treschnitzer; Helmut Kässmann; Christian Pirich; Raphael Reiter Journal: BMC Geriatr Date: 2016-02-29 Impact factor: 3.921